ClinicalTrials.Veeva

Menu
C

CenExel Clinical Research | Anaheim Clinical Trials

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

VX-548
Risankizumab
PF-06291874
PF-06882961
PF-06700841
PF-07081532
LY3502970
Acetaminophen
Rosuvastatin
Midazolam

Parent organization

This site is a part of CenExel Clinical Research

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

18 of 212 total trials

A Single Dose Study to Assess Adverse Events and How Oral Icalcaprant Moves Through the Body in Healthy Adult Japanese and Han Chinese Participants (528 Asian PK)

This study will assess the pharmacokinetics, safety, and tolerability of icalcaprant administered orally in healthy adult Japanese and Han Chinese pa...

Enrolling
Healthy Volunteer
Drug: Icalcaprant

The purpose of this study is to learn if modified RNA (modRNA) vaccines for the prevention of influenza are:* safe; and* how these vaccines produce a...

Active, not recruiting
Influenza, Human
Biological: Influenza ModRNA Vaccine
Biological: Quadrivalent Influenza Vaccine (QIV)

The purpose of this study is to evaluate the efficacy and safety of rocatinlimab in monotherapy treatment.

Active, not recruiting
Atopic Dermatitis
Drug: Rocatinlimab
Drug: Placebo

The main purpose of this study is to assess the dose-response relationship of maridebart cafraglutide on glucose control compared with placebo.

Enrolling
Type 2 Diabetes Mellitus (T2DM)
Drug: Maridebart Cafraglutide
Drug: Placebo

The purpose of this study (Part 1 and Part 2) is to evaluate the relative vaccine efficacy (rVE), safety, reactogenicity, and immunogenicity of mRNA-...

Active, not recruiting
COVID-19
Biological: mRNA-1283.222
Biological: mRNA-1273.815

This study is to evaluate the Pharmacodynamic (PD), safety, tolerability, Pharmacokinetic (PK), and plasma biomarker response of KAN-101 in participa...

Active, not recruiting
Celiac Disease
Drug: Cohort 2 in Part A
Drug: Group 4 in Part B and Part C

The purpose of this study is to assess the safety, tolerability, and pharmacokinetics (PK) of multiple doses of KarXT + KarX-EC capsules versus KarXT...

Enrolling
Healthy Volunteers
Drug: Placebo
Drug: Omeprazole

The main purpose of this study is to see how much of orforglipron (study drug) gets into the bloodstream and how long it takes the body to get rid of...

Enrolling
Overweight
Obese
Drug: Orforglipron

The purpose of the study is to learn how the study medicine called PF-07868489 is tolerated and acts in healthy adult people and people with pulmonar...

Enrolling
Pulmonary Arterial Hypertension
Drug: Placebo for PF-07868489
Drug: PF-07868489

The purpose of the study is to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of multiple escalating oral doses o...

Enrolling
Type 2 Diabetes Mellitus (T2DM)
Obesity
Drug: Rosuvastatin
Drug: Omeprazole

The purpose of this study is to learn the following about the study medicine, danuglipron, after multiple days of dosing in healthy adults who are ov...

Enrolling
Obesity
Drug: Rosuvastatin
Drug: Atorvastatin

This study is researching experimental drugs called trevogrumab and garetosmab (called "study drugs") in combination with another drug, semaglutide (...

Active, not recruiting
Obesity
Drug: Matching Placebo-Trevogrumab
Drug: Matching Placebo-Garetosmab

The primary objective of this study is to evaluate the analgesic efficacy of DMTS, compared with placebo, in subjects following abdominoplasty.

Enrolling
Pain, Postoperative
Drug: Placebo Patch
Drug: DMTS Patch

The purpose of the study is to evaluate the safety, tolerability, and pharmacokinetics of escalating single and repeat doses of PF-07832837 in health...

Enrolling
Atopic Dermatitis
Healthy Participants
Other: Placebo
Drug: PF-07832837

This is a multicenter, randomized, double-blind, Phase 2b/3 study to evaluate the efficacy and safety of ABP-671. Part 1 of the study will compare th...

Active, not recruiting
Gout
Other: Placebo
Drug: Allopurinol

Researchers are looking for new ways to prevent cancers related to human papillomavirus (HPV). HPV is a common virus that can cause an infection. The...

Enrolling
Healthy
Biological: V540B
Biological: GARDASIL®9 (G9)

The primary objective of this study is to assess the safety and tolerability of AMG 513 after single and multiple doses.

Enrolling
Cardiometabolic Disease
Drug: Placebo
Drug: AMG 513

An antibody is a substance your body makes to fight off infection. This study will explore the safety and antibody response of a vaccine to prevent s...

Active, not recruiting
Clostridoides Difficile Associated Disease
Biological: C. difficile vaccine formulation 1.
Other: Saline Placebo.

Trial sponsors

Pfizer logo
Lilly logo
Bristol-Myers Squibb (BMS) logo
AbbVie logo
Vertex Pharmaceuticals logo
Amgen logo
Celgene logo
H
Novavax logo
BioNTech logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems